Peptide Stacking 101: The Wolverine Stack, Longevity Protocol & Cognitive Stack Explained

Peptide stacking is having a moment. National Geographic ran a feature on biohackers combining tissue-repair compounds. Harper's Bazaar published a longevity-focused roundup citing Epithalon by name. Goop did what Goop does — enthusiastically endorsed several peptide stacks while carefully omitting the parts about FDA status.

The global peptide therapeutics market hit approximately $11 billion in 2025 and is projected to nearly double by 2030. A meaningful slice of that growth isn't coming from pharmaceutical development — it's coming from individuals, athletes, and practitioners building their own multi-peptide protocols and calling them "stacks."

Three stacks dominate the current conversation. Each has a distinct goal, a distinct evidence tier, and a distinct set of things the wellness press tends to gloss over. This article covers all three — what they actually are, what the science shows, and where the hype outpaces the data.

What Is Peptide Stacking — and Why Is It Exploding Now?

Peptide stacking means running two or more peptides simultaneously in a single protocol, targeting overlapping or complementary biological goals. The rationale: most peptides have narrow mechanisms. BPC-157 excels at tissue repair. TB-500 excels at systemic inflammation and cell migration. No single peptide does everything — so users combine them.

The explosion of interest in stacking has three drivers:

1. Mainstream coverage normalization. When National Geographic writes about regenerative peptides and Harper's Bazaar covers longevity protocols, the audience shifts from biohackers to educated general consumers. Demand follows attention.
2. Practitioner adoption. A growing number of functional medicine physicians, sports medicine doctors, and longevity clinics are incorporating peptides into supervised protocols. This creates legitimacy signals that consumer audiences notice.
3. The GLP-1 halo effect. Semaglutide and tirzepatide normalized the idea that peptides could produce meaningful physiological changes. People who've seen GLP-1 work are more willing to explore adjacent research peptides.

The three stacks below represent the highest-traffic, highest-discussion protocols in the peptide community right now. None of them are FDA-approved treatments. All of them have legitimate mechanistic rationale. The evidence quality varies significantly between them.

Stack #1: The Wolverine Stack (BPC-157 + TB-500)

The "Wolverine Stack" name is a community invention — a reference to the Marvel character's near-instant healing ability. The name is marketing. The mechanism is not.

BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic peptide derived from a protective protein found in gastric juice. It's been studied across dozens of tissue types in animal models, with consistent results in:

• Soft tissue healing: tendons, ligaments, muscle, gut wall
• Angiogenesis: promotes new blood vessel formation at injury sites
• Growth hormone receptor upregulation in mucosal tissue
• Anti-inflammatory modulation without broad immunosuppression

TB-500 is a synthetic analog of thymosin beta-4 (Tβ4), a naturally occurring protein that regulates actin polymerization — the cellular machinery that governs how cells move, extend, and reorganize during tissue repair. TB-500 acts systemically: it promotes cell migration across a wide range of tissue types, reduces fibrosis, and modulates inflammation through pathways distinct from BPC-157.

The stacking argument is strong here. BPC-157 drives repair signals at the injury site — growth factor cascades, angiogenesis, mucosal healing. TB-500 drives cellular remodeling systemically — the cell migration and actin dynamics that allow new tissue to organize properly. They don't compete; they complement.

Wolverine Stack: Evidence Breakdown

Wolverine Stack: Protocol

• BPC-157: 250–500 mcg daily (subcutaneous or oral for gut; SubQ for systemic injury); twice daily dosing common for acute injury
• TB-500: 2–5 mg twice weekly (subcutaneous); loading phase of 4–6 mg/week for first 4 weeks, then 2–3 mg/week maintenance
• Duration: 4–8 weeks for acute injury; up to 12 weeks for chronic issues
• Cycling: No strict cycle required for acute recovery; for ongoing maintenance many use 8 weeks on / 4 weeks off

Stack #2: The Longevity Protocol (Epithalon + MOTS-c + NAD+)

The Longevity Protocol is where peptide stacking moves from the gym into the lab. These three compounds target aging at the cellular level — and they're increasingly the subject of serious academic and investor attention, not just biohacker forums.

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Russian researcher Vladimir Khavinson at the St. Petersburg Institute of Bioregulation. Its primary studied mechanism: activation of telomerase — the enzyme responsible for maintaining telomere length during cellular division. Telomere shortening is one of the most reproducible hallmarks of cellular aging, and its attenuation is one of the most active areas of longevity research. Epithalon has also been studied for its effects on circadian rhythm normalization and melatonin production.

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a mitochondria-derived peptide — one of a new class of signaling molecules called "mitokines." It's encoded in mitochondrial DNA rather than nuclear DNA, which is unusual. MOTS-c activates AMPK (AMP-activated protein kinase) — the master metabolic regulator that governs energy homeostasis, mitochondrial biogenesis, and cellular stress responses. In animal studies, MOTS-c has shown effects on insulin sensitivity, body composition, and lifespan extension. Human Phase 1 trials are ongoing.

NAD+ (nicotinamide adenine dinucleotide) is not technically a peptide — it's a coenzyme — but it's increasingly included in longevity stacks because of its relationship with mitochondrial function. NAD+ levels decline with age, and its depletion impairs sirtuin activation, DNA repair, and mitochondrial efficiency. Supplementation via precursors (NMN or NR) or direct IV infusion aims to restore NAD+ levels. It's the most commercially developed compound in this stack, with multiple Phase 2 clinical trials underway.

How the Three Work Together

The mechanistic logic here is more sophisticated than the Wolverine Stack:

• Epithalon targets the chromosomal limit on cell division — telomere length
• MOTS-c targets mitochondrial energy production and metabolic resilience — the fuel system of longevity
• NAD+ targets the enzymatic infrastructure that both systems depend on — sirtuins, PARP enzymes, and the cellular stress response machinery

The theory is complementary coverage across three distinct aging vectors. Epithalon at the nuclear level, MOTS-c at the mitochondrial level, NAD+ at the metabolic infrastructure level. Each acts through mechanisms the others don't replicate.

Longevity Protocol: Evidence Breakdown

Longevity Protocol: Protocol

• Epithalon: 5–10 mg daily (subcutaneous or intranasal); traditionally cycled 10–20 days on / 4–6 months off; some practitioners use 2–4 week annual cycles
• MOTS-c: 5–15 mg 2–3× weekly (subcutaneous); typically cycled 4–8 weeks on / 4 weeks off; morning dosing preferred as AMPK activation can be energizing
• NAD+: NMN 500–1,000 mg daily oral; NR 300–500 mg daily oral; or IV NAD+ 500–1,000 mg weekly (clinic-administered); IV has faster onset but oral precursors are more accessible
• Important: Epithalon requires cycling. Running it continuously is not supported by available protocols and may be counterproductive.

Stack #3: The Cognitive Stack (Semax + Selank)

The Cognitive Stack is the most accessible of the three — lower cost, nasal administration (no injection required for most users), and relatively fast subjective onset. It's also the most culturally interesting: both peptides come from Soviet-era neuroscience research and were developed specifically for cognitive enhancement in high-demand environments.

Semax is a synthetic heptapeptide analog of ACTH (adrenocorticotropic hormone) developed in Russia in the 1980s. It works primarily through BDNF upregulation — brain-derived neurotrophic factor, the protein responsible for neuronal growth, plasticity, and survival. BDNF is sometimes described as "fertilizer for the brain": it supports the formation of new synaptic connections, protects existing neurons from damage, and plays a central role in learning and memory consolidation.

Semax also modulates acetylcholine signaling and dopaminergic activity, contributing to its focus-enhancing effects. Unusually for a peptide, it's registered as a pharmaceutical in Russia and Ukraine — where it's prescribed for stroke recovery, cognitive decline, and attention disorders — giving it a more substantial human-use history than most research peptides.

Selank is a synthetic analog of tuftsin (a natural immunomodulatory peptide) with an additional stabilizing sequence attached. It was developed at the Institute of Molecular Genetics in Moscow specifically as an anxiolytic — but unlike benzodiazepines (which produce sedation and carry addiction risk), Selank appears to reduce anxiety through enkephalin metabolism modulation and GABAergic system support, without significant sedation or withdrawal potential.

The stacking rationale: Semax drives upward (focus, cognitive activation, BDNF). Selank modulates downward (anxiety reduction, calm without sedation). Together they produce a state that the community describes as "focused calm" — cognitive sharpness without the edginess that stimulants produce. They target complementary neurotransmitter systems and don't produce competitive effects.

Cognitive Stack: Evidence Breakdown

Cognitive Stack: Protocol

• Semax: 100–500 mcg intranasally (2–4 drops of 0.1% solution), 1–2× daily; morning dosing preferred — can be energizing; some users report mild headache at higher doses
• Selank: 300–900 mcg intranasally, 1–2× daily; can be taken simultaneously or offset from Semax by 30–60 minutes
• Duration: Typically 2–4 weeks on, 1–2 weeks off; continuous use may produce tolerance — take breaks
• Storage: Nasal solutions are less stable than lyophilized peptides; refrigerate and use within 30 days once reconstituted; some users prefer lyophilized powder reconstituted fresh for each use

Side-by-Side: Which Stack Is Right for Your Goal?

Is Peptide Stacking Safe? What Goop Won't Tell You

Let's be direct about something the wellness press consistently sidesteps: we do not have robust human safety data on any of these stacks.

The Wolverine Stack has the most reassuring safety profile — both BPC-157 and TB-500 appear well-tolerated in animal models, and community reports across hundreds of thousands of users suggest minimal adverse effects at standard doses. But "well-tolerated in animal models" is not the same as "proven safe for long-term human use." There are no five-year longitudinal human studies. There is no pharmacovigilance database tracking adverse events at scale.

The Longevity Protocol carries specific considerations that deserve attention:

The telomerase question. Epithalon's mechanism — activating telomerase — is exactly what certain cancer cells exploit to become "immortal." While Epithalon has shown anti-tumorigenic properties in some preclinical studies, and no causal link to cancer has been established, anyone with a personal or family history of cancer should discuss telomerase-activating interventions with an oncologist before proceeding.

MOTS-c is early-stage. Phase 1 human safety data is emerging, but long-term effects in healthy populations are unknown. NAD+ precursors have the cleanest human safety record of the three — but high-dose supplementation can have GI effects, and interactions with certain medications (particularly those affecting NAD+ metabolism) haven't been fully characterized.

The Cognitive Stack is generally considered the lowest-risk of the three — particularly for short cycles. However, Semax affects BDNF and dopaminergic signaling. Anyone with a personal or family history of bipolar disorder, psychosis, or medication-sensitive dopamine dysregulation should approach with caution and medical oversight.

The honest summary: These stacks are being used by thousands of people with generally positive self-reported outcomes. That's meaningful signal. It's not the same as proven safety. The wellness press that presents these protocols without noting the evidence gaps is prioritizing engagement over accuracy. We'd rather you make an informed decision.

Safety Considerations: Interaction Risks and Timing

Peptide-Peptide Interactions

Within each of the three stacks described above, there are no known direct peptide-peptide interaction risks. The mechanisms are complementary and non-overlapping. The primary risk within a stack is over-stimulation of a shared downstream pathway at higher doses — not direct chemical interaction.

Cross-stack stacking (running multiple stacks simultaneously) is a different matter. Running the Wolverine Stack + the Cognitive Stack simultaneously is generally considered low-risk given their distinct mechanisms. Adding the Longevity Protocol on top of either, however, introduces more variables. Most experienced practitioners recommend running one stack at a time, establishing your response, then layering rather than starting with a full three-stack protocol.

Drug Interactions

Known or suspected interaction considerations:

• BPC-157 + blood thinners: BPC-157 has some observed effects on platelet aggregation in preclinical studies. No confirmed interaction, but mention to your physician if on anticoagulants.
• MOTS-c + metformin or diabetes medications: Both activate AMPK. Theoretical risk of additive glucose-lowering effects. Monitor blood glucose if combining.
• NAD+ precursors + PARP inhibitors: NAD+ is the substrate PARP enzymes consume during DNA repair. PARP inhibitors (used in oncology) and NAD+ supplementation may interact — discuss with your oncologist.
• Selank + benzodiazepines or GABA-modulating medications: Selank has GABAergic activity. Additive effects with prescribed anxiolytics or sedatives are possible. Don't combine without physician involvement.

Timing Your Stack: The Practical Guide

When running any of these stacks, timing matters for two reasons: maximizing efficacy and managing half-life overlap.

The $11B Market and When Stacking Makes Sense vs. Hype

The peptide therapeutics market is large and growing for legitimate reasons — pharmaceutical-grade peptide drugs like semaglutide, liraglutide, and various cancer peptides have real, validated clinical utility. The research peptide market that powers these stacks is a different animal: less regulated, less studied in humans, but not inherently illegitimate.

Stacking makes sense when:

• You have a specific, defined goal (injury recovery, cognitive performance, longevity support)
• You've researched both peptides individually first
• You start with a single proven stack, not three at once
• You're working with a physician who can monitor relevant biomarkers
• You can distinguish between subjective improvements and measurable outcomes

Stacking is hype when:

• You're combining 6+ peptides based on forum posts
• The claims involve "reversing aging" or "regenerating organs"
• There's no cycling protocol — as if peptide receptors don't desensitize
• The source is Goop, a supplement company press release, or a biohacker's personal blog with affiliate links

The three stacks in this article are all defensible — but "defensible" means "mechanistically plausible with preclinical support" not "proven safe and effective in humans." That distinction matters.

Frequently Asked Questions

What is the Wolverine Stack?

The Wolverine Stack is a community term for the combination of BPC-157 and TB-500 — two peptides with complementary tissue repair mechanisms. BPC-157 drives localized angiogenesis and growth factor signaling at injury sites; TB-500 supports systemic cell migration and tissue remodeling through actin regulation. Together they're the most evidence-supported peptide stack for soft tissue recovery.

What is the Longevity Protocol in peptides?

The Longevity Protocol typically refers to a combination of Epithalon (telomerase activation), MOTS-c (mitochondrial function and AMPK activation), and NAD+ precursors (cellular energy metabolism and sirtuin activation). It targets three distinct mechanisms of cellular aging simultaneously. Evidence quality varies significantly between the three compounds.

What does the Cognitive Stack (Semax + Selank) do?

Semax upregulates BDNF and modulates dopaminergic and cholinergic activity, producing enhanced focus and cognitive clarity. Selank reduces anxiety through enkephalin metabolism and GABAergic support without sedation or addiction risk. Combined, they're described as producing "focused calm" — the cognitive benefits of Semax without stimulant-associated anxiety.

Can you run all three stacks at the same time?

Theoretically possible — the mechanisms are distinct enough that direct peptide-peptide conflicts are unlikely. Practically, this is not recommended. Running multiple stacks simultaneously makes it impossible to attribute effects to specific compounds, complicates cycling, and increases total metabolic load. Start with one stack, establish your response, then layer if warranted.

Which peptide stack has the most human evidence?

The Wolverine Stack (BPC-157 + TB-500) has the strongest preclinical evidence base of the three. Thymosin beta-4 (TB-500's parent molecule) has Phase 1 human safety data. BPC-157 has a 2025 systematic review covering 36 studies. No large randomized controlled trials exist for any of these stacks in healthy humans.

How long should you run a peptide stack?

Depends on the stack and goal. Wolverine Stack: 4–12 weeks; Longevity Protocol: Epithalon in strict 10–20 day cycles, MOTS-c in 4–8 week cycles; Cognitive Stack: 2–4 weeks on, 1–2 weeks off. The universal rule: build in off-periods to prevent receptor desensitization and allow your body to readjust. Continuous indefinite use is not supported by available data for any of these compounds.

Do peptide stacks require blood work monitoring?

Recommended, especially for the Longevity Protocol. Relevant markers: IGF-1 (MOTS-c and any GH-adjacent peptide), fasting glucose (MOTS-c's AMPK effects), NAD+ levels (direct measure or proxy via NADH/NADP), and standard metabolic panel (liver/kidney function for peptide clearance). For the Cognitive Stack, no biomarker monitoring is strictly necessary but a neurological baseline is useful for anyone with a psychiatric history.

Is Goop's peptide coverage accurate?

Goop and similar wellness publications generally cover the mechanisms accurately (peptides do what they describe) but omit the evidence limitations consistently (no human RCTs, no long-term safety data). The issue isn't that they're wrong — it's that they're incomplete. The signal-to-hype ratio in wellness coverage of peptide stacks is low. This article exists to correct that.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. The peptides discussed — BPC-157, TB-500, Epithalon, MOTS-c, Semax, and Selank — are research compounds not approved by the FDA for the treatment or prevention of any disease or condition. None of the stacks described have been evaluated in large-scale randomized controlled trials in humans. Always consult a qualified healthcare provider before starting any new supplement, peptide, or protocol, especially if you have a medical condition, are taking medications, or are pregnant or breastfeeding. WellSourced may contain affiliate links. See our full affiliate disclosure.